Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Rousselle

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Regulatory Toxicology and Pharmacology : RTP|September 22, 2018
Opinion of the scientific committee on consumer safety (SCCS) - Opinion on the safety of cosmetic ingredient phenylene bis-diphenyltriazine (CAS No 55514-22-2) - S86, , Christophe Rousselle, et al.
Toxics|February 28, 2023
Editorial for the Special Issue on "Human Biomonitoring in Health Risk Assessment: Current Practices and Recommendations for the Future"Christophe Rousselle
Regulatory Toxicology and Pharmacology : RTP|September 13, 2015
Opinion of the Scientific Committee on Consumer Safety (SCCS)--Revision of the opinion on the safety of aluminium in cosmetic products, Christophe Rousselle
Regulatory Toxicology and Pharmacology : RTP|November 19, 2016
Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the Opinion on Vitamin A (retinol, retinyl acetate and retinyl palmitate) in cosmetic products, Christophe Rousselle
Regulatory Toxicology and Pharmacology : RTP|November 16, 2016
Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the opinion on decamethylcyclopentasiloxane (cyclopentasiloxane, D5) in cosmetic products, Dr Christophe Rousselle
La Revue Du Praticien|December 2, 2006
[Problems posed by genetic diseases, concerning DNA instability disorders: fragile X syndrome]Gaëtan Lesca, Christophe Rousselle
La Revue Du Praticien|March 16, 2010
[Problems posed by genetic diseases, concerning DNA instability disorders: fragile X syndrome]Gaëtan Lesca, Aurore Curie, Christophe Rousselle
Advances and Technical Standards in Neurosurgery|May 11, 2026
Pineal Region Tumors: Clinical Symptoms and SyndromesPierre-Aurélien Beuriat, Christophe Rousselle, Isabelle Sabatier
Molecular and Cellular Endocrinology|August 29, 2018
Special issue: Is BPA an ED?Claire Beausoleil, Elodie Pasquier, Christophe Rousselle, et al.
Pharmaceutical Research|September 14, 2004
In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrierSalvatore Cisternino, Christophe Rousselle, Marcel Debray, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Regulatory Toxicology and Pharmacology : RTP|September 22, 2018
Opinion of the scientific committee on consumer safety (SCCS) - Opinion on the safety of cosmetic ingredient phenylene bis-diphenyltriazine (CAS No 55514-22-2) - S86, , Christophe Rousselle, et al.
Toxics|February 28, 2023
Editorial for the Special Issue on "Human Biomonitoring in Health Risk Assessment: Current Practices and Recommendations for the Future"Christophe Rousselle
Regulatory Toxicology and Pharmacology : RTP|September 13, 2015
Opinion of the Scientific Committee on Consumer Safety (SCCS)--Revision of the opinion on the safety of aluminium in cosmetic products, Christophe Rousselle
Regulatory Toxicology and Pharmacology : RTP|November 19, 2016
Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the Opinion on Vitamin A (retinol, retinyl acetate and retinyl palmitate) in cosmetic products, Christophe Rousselle
Regulatory Toxicology and Pharmacology : RTP|November 16, 2016
Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the opinion on decamethylcyclopentasiloxane (cyclopentasiloxane, D5) in cosmetic products, Dr Christophe Rousselle
La Revue Du Praticien|December 2, 2006
[Problems posed by genetic diseases, concerning DNA instability disorders: fragile X syndrome]Gaëtan Lesca, Christophe Rousselle
La Revue Du Praticien|March 16, 2010
[Problems posed by genetic diseases, concerning DNA instability disorders: fragile X syndrome]Gaëtan Lesca, Aurore Curie, Christophe Rousselle
Advances and Technical Standards in Neurosurgery|May 11, 2026
Pineal Region Tumors: Clinical Symptoms and SyndromesPierre-Aurélien Beuriat, Christophe Rousselle, Isabelle Sabatier
Molecular and Cellular Endocrinology|August 29, 2018
Special issue: Is BPA an ED?Claire Beausoleil, Elodie Pasquier, Christophe Rousselle, et al.
Pharmaceutical Research|September 14, 2004
In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrierSalvatore Cisternino, Christophe Rousselle, Marcel Debray, et al.
Pageof 7